507 related articles for article (PubMed ID: 20627592)
1. Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides.
Choi WJ; Kim YM; Kim HO; Lee HW; Kim DE; Park KS; Chong Y; Jeong LS
Bioorg Med Chem; 2010 Jul; 18(13):4812-20. PubMed ID: 20627592
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3'-C-hydroxymethyl-substituted pyrimidine and purine nucleosides as potential anti-hepatitis C virus (HCV) agents.
Pei X; Choi WJ; Kim YM; Zhao LX; Jeong LS
Arch Pharm Res; 2008 Jul; 31(7):843-9. PubMed ID: 18704325
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral evaluation of 4'-C-azidomethyl-beta-D-ribofuranosyl purine and pyrimidine nucleosides.
Griffon JF; Dumas A; Storer R; Sommadossi JP; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):435-49. PubMed ID: 20183594
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents.
Chun BK; Wang P; Hassan A; Du J; Tharnish PM; Murakami E; Stuyver L; Otto MJ; Schinazi RF; Watanabe KA
Nucleosides Nucleotides Nucleic Acids; 2007; 26(1):83-97. PubMed ID: 17162589
[TBL] [Abstract][Full Text] [Related]
5. Suppression of subgenomic hepatitis C virus replication by 5'-O-masked analogues of 6-chloropurine-2'-deoxyriboside.
Ikejiri M; Ohshima T; Kato K; Toyama M; Murata T; Shimotohno K; Maruyama T
Nucleic Acids Symp Ser (Oxf); 2007; (51):439-40. PubMed ID: 18029775
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 9-(2-beta-C-methyl-beta-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication.
Ding Y; Girardet JL; Hong Z; Lai VC; An H; Koh YH; Shaw SZ; Zhong W
Bioorg Med Chem Lett; 2005 Feb; 15(3):709-13. PubMed ID: 15664842
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication.
Clark JL; Mason JC; Hollecker L; Stuyver LJ; Tharnish PM; McBrayer TR; Otto MJ; Furman PA; Schinazi RF; Watanabe KA
Bioorg Med Chem Lett; 2006 Mar; 16(6):1712-5. PubMed ID: 16368235
[TBL] [Abstract][Full Text] [Related]
8. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents.
Liu LJ; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):216-27. PubMed ID: 20408052
[TBL] [Abstract][Full Text] [Related]
10. The novel unsaturated acyclic nucleoside analogues: cytostatic and antiviral activity evaluations.
Wittine K; Benci K; Pavelić SK; Pavelić K; Mintas M
Nucleic Acids Symp Ser (Oxf); 2008; (52):601-2. PubMed ID: 18776523
[TBL] [Abstract][Full Text] [Related]
11. 4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agents.
Shakya N; Vedi S; Liang C; Yang F; Agrawal B; Kumar R
Bioorg Med Chem Lett; 2014 Mar; 24(5):1407-9. PubMed ID: 24485784
[TBL] [Abstract][Full Text] [Related]
12. 4'-C-methyl-beta-D-ribofuranosyl purine and pyrimidine nucleosides revisited.
Griffon JF; Dukhan D; Pierra C; Benzaria S; Loi AG; La Colla P; Sommadossi JP; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):707-9. PubMed ID: 14565259
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents.
Yoo BN; Kim HO; Moon HR; Seol SK; Jang SK; Lee KM; Jeong LS
Bioorg Med Chem Lett; 2006 Aug; 16(16):4190-4. PubMed ID: 16781148
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV and anti-HBV activities of 2'-fluoro-2', 3'-unsaturated L-nucleosides.
Lee K; Choi Y; Gullen E; Schlueter-Wirtz S; Schinazi RF; Cheng YC; Chu CK
J Med Chem; 1999 Apr; 42(7):1320-8. PubMed ID: 10197975
[TBL] [Abstract][Full Text] [Related]
15. Coumarin-purine ribofuranoside conjugates as new agents against hepatitis C virus.
Hwu JR; Lin SY; Tsay SC; De Clercq E; Leyssen P; Neyts J
J Med Chem; 2011 Apr; 54(7):2114-26. PubMed ID: 21375337
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 2'-beta-C-methyl toyocamycin and sangivamycin analogues as potential HCV inhibitors.
Ding Y; An H; Hong Z; Girardet JL
Bioorg Med Chem Lett; 2005 Feb; 15(3):725-7. PubMed ID: 15664845
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral evaluation of 7-fluoro-7-deaza-2-aminopurine nucleoside derivatives.
Leroy F; Chaves D; Dukhan D; Storer R; Sommadossi JP; Loi AG; Cadeddu A; Fanti M; Boscu N; Bassetti F; Liuzzi M; Gosselin G
Nucleic Acids Symp Ser (Oxf); 2008; (52):595-6. PubMed ID: 18776520
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, cytostatic and anti-HCV activity of 6-(N-substituted aminomethyl)-, 6-(O-substituted hydroxymethyl)- and 6-(S-substituted sulfanylmethyl)purine nucleosides.
Silhár P; Hocek M; Pohl R; Votruba I; Shih IH; Mabery E; Mackman R
Bioorg Med Chem; 2008 Mar; 16(5):2329-66. PubMed ID: 18078757
[TBL] [Abstract][Full Text] [Related]
19. Cytostatic and antiviral 6-arylpurine ribonucleosides. Part 7: synthesis and evaluation of 6-substituted purine l-ribonucleosides.
Hocek M; Silhár P; Shih IH; Mabery E; Mackman R
Bioorg Med Chem Lett; 2006 Oct; 16(20):5290-3. PubMed ID: 16905315
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides.
Nauš P; Caletková O; Konečný P; Džubák P; Bogdanová K; Kolář M; Vrbková J; Slavětínská L; Tloušt'ová E; Perlíková P; Hajdúch M; Hocek M
J Med Chem; 2014 Feb; 57(3):1097-110. PubMed ID: 24397620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
